BRIEF-Minerva Neurosciences Top Line Results From Phase 3 Trial

BRIEF-Minerva Neurosciences Top Line Results From Phase 3 Trial With Roluperidone In Negative Symptoms In Patients Diagnosed With Schizophrenia On Track For Release In Q2

So could there be a treatment for negatives next year ?

8 Likes

According to the expert in this treatments review video, Loving Kindness Meditation has an effect size of 1.7 against negative symptoms.

1.7 is a huge effect size and will probably not be matched by any drug in the near future.

1 Like

Give it a go and report back to us !

1 Like

Anyone knows if there are side effects when using roluperidone?

Ok, will do.

I was afraid to try it until now as I’m already too nice as a person and a bit of a ‘yes man’ and people pleaser, but I’m willing to volunteer for the greater good.

1 Like

How do I download the article/review?
I will try it if it makes it b4 karxt.

https://finance.yahoo.com/news/minerva-neurosciences-reports-first-quarter-113010706.html

3 Likes

Do you know when it will be FDA approved?
Once its FDA approved my pdr said it takes around 5 years to reach Canada.

1 Like

The phase 3 trial results will be known next year. If it passes phase 3 then it will probably be approved next year.

2 Likes

Many years probably 7-8 years ago on the old forum there was a pretty hyped drug named,bitopertin.It’s formulated similar to sarcosine,but made as a medicine.One day I even called they meds company Roche to ask if there is trial.It end up not being approved.I was so disappointed that time,now I probably won’t get hyped for new negative symptoms drug,but hope it can get true all the trial and be able to be prescribed by a doctor

1 Like